Current concepts in the pathogenesis of psoriasis.

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMC 2800878)

Published in Indian J Dermatol on January 01, 2009

Authors

Rajeev Patrick Das1, Arun Kumar Jain, V Ramesh

Author Affiliations

1: Institute of Pathology (ICMR), Safdarjang Hospital and Vardhman Mahavir Medical College, New Delhi, India.

Articles cited by this

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol (2005) 30.22

IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol (2006) 10.33

Regulation of wound healing by growth factors and cytokines. Physiol Rev (2003) 9.82

Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity (2005) 6.71

Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell (1997) 6.70

Interleukin-17 promotes angiogenesis and tumor growth. Blood (2002) 4.90

Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J Exp Med (1998) 4.16

Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med (2004) 4.02

Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol (1998) 3.18

Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci U S A (1989) 2.87

Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum Mol Genet (1997) 2.48

In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. J Immunol (2006) 2.44

Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet (1997) 2.43

The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J Cell Biol (1997) 2.29

Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am J Pathol (1991) 2.24

Molecular uncoupling of fractalkine-mediated cell adhesion and signal transduction. Rapid flow arrest of CX3CR1-expressing cells is independent of G-protein activation. J Biol Chem (1999) 2.24

Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis (2005) 2.24

The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol (2002) 2.15

Linkage analysis of human leukocyte antigen (HLA) markers in familial psoriasis: strong disequilibrium effects provide evidence for a major determinant in the HLA-B/-C region. Am J Hum Genet (1998) 2.09

The pathogenesis of psoriasis: immunological facts and speculations. Immunol Today (1999) 2.08

Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science (1994) 1.99

The natural history of psoriasis in 5,600 patients. Dermatologica (1974) 1.98

The genetics of psoriasis: a complex disorder of the skin and immune system. Hum Mol Genet (1998) 1.94

Development and use of alefacept to treat psoriasis. J Am Acad Dermatol (2003) 1.62

Association analysis using refined microsatellite markers localizes a susceptibility locus for psoriasis vulgaris within a 111 kb segment telomeric to the HLA-C gene. Hum Mol Genet (1999) 1.60

S100 protein subcellular localization during epidermal differentiation and psoriasis. J Histochem Cytochem (2003) 1.58

Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis. J Invest Dermatol (1986) 1.56

Marked synergism between tumor necrosis factor-alpha and interferon-gamma in regulation of keratinocyte-derived adhesion molecules and chemotactic factors. J Clin Invest (1990) 1.54

A susceptibility gene for psoriatic arthritis maps to chromosome 16q: evidence for imprinting. Am J Hum Genet (2002) 1.45

Paracrine regulation of keratinocyte proliferation and differentiation. Trends Cell Biol (2001) 1.43

Anti-angiogenic therapy: rationale, challenges and clinical studies. Angiogenesis (2002) 1.40

International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature. Pharmacol Rev (2002) 1.37

Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. Am J Pathol (1994) 1.34

Characterization of the major susceptibility region for psoriasis at chromosome 6p21.3. J Invest Dermatol (1999) 1.32

Genomewide scan in german families reveals evidence for a novel psoriasis-susceptibility locus on chromosome 19p13. Am J Hum Genet (2000) 1.30

Evidence that a locus for familial psoriasis maps to chromosome 4q. Nat Genet (1996) 1.27

Differential expression of GRO-alpha and IL-8 mRNA in psoriasis: a model for neutrophil migration and accumulation in vivo. J Invest Dermatol (1996) 1.24

Identification of a novel psoriasis susceptibility locus at 1p and evidence of epistasis between PSORS1 and candidate loci. J Med Genet (2001) 1.23

Evidence for interaction between psoriasis-susceptibility loci on chromosomes 6p21 and 1q21. Am J Hum Genet (1999) 1.21

Psoriasin (S100A7). Int J Biochem Cell Biol (1998) 1.20

Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes. J Clin Invest (1995) 1.19

Genetics of psoriasis: the potential impact on new therapies. J Am Acad Dermatol (2003) 1.17

Interleukin 2 and psoriasis. Arch Dermatol (1988) 1.14

The genetics of psoriasis 2001: the odyssey continues. Arch Dermatol (2001) 1.14

Cytokines in psoriasis. Int J Dermatol (1999) 1.12

Psoriasis susceptibility locus in chromosome region 3q21 identified in patients from southwest Sweden. Eur J Hum Genet (2000) 1.09

A genome-wide search for genes predisposing to familial psoriasis by using a stratification approach. Hum Genet (1999) 1.08

Angiogenesis in psoriasis. Angiogenesis (2002) 1.08

Etanercept: An overview. J Am Acad Dermatol (2003) 1.06

The insulin-like growth factor I receptor is overexpressed in psoriatic epidermis, but is differentially regulated from the epidermal growth factor receptor. J Exp Med (1992) 1.03

Recent developments in the understanding of the pathogenesis of psoriasis. Br J Dermatol (1999) 1.00

Infliximab for psoriasis. J Am Acad Dermatol (2003) 0.97

Genetics of psoriasis. Arch Dermatol Res (1998) 0.97

Role of NGF and neurogenic inflammation in the pathogenesis of psoriasis. Prog Brain Res (2004) 0.95

Characterization of lymphocyte-dependent angiogenesis using a SCID mouse: human skin model of psoriasis. J Investig Dermatol Symp Proc (2000) 0.95

T-cell activation is potentiated by cytokines released by lesional psoriatic, but not normal, epidermis. Arch Dermatol (1992) 0.93

The inflammatory infiltrate in psoriasis. Clin Dermatol (1995) 0.92

The immunology of psoriasis and biologic immunotherapy. J Am Acad Dermatol (2003) 0.88

Nerve growth factor and keratinocytes: a role in psoriasis. Eur J Dermatol (2000) 0.88

Psoriasis and cyclosporin: immunohistochemical aspects of the basement membrane. Acta Derm Venereol Suppl (Stockh) (1994) 0.80

Pathogenesis of psoriasis. Dermatol Clin (1995) 0.79

Inhibition of angiogenesis by 15-deoxyspergualin. J Antibiot (Tokyo) (1991) 0.79

Topical calcipotriene in combination with UVB phototherapy for psoriasis. Int J Dermatol (1997) 0.77

Immunohistochemical localization of basic fibroblast growth factor in skin diseases. Acta Derm Venereol (1993) 0.76

Psoriasis: the future. Br J Dermatol (2001) 0.76

Articles by these authors

Shape, size, and distribution of Ca(2+) release units and couplons in skeletal and cardiac muscles. Biophys J (1999) 5.37

A prospective study of prevalence and association of peripheral neuropathy in Indian patients with newly diagnosed type 2 diabetes mellitus. J Postgrad Med (2014) 3.53

Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet (2001) 3.39

The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane. Trends Biochem Sci (1998) 3.24

Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain (2006) 3.16

Regulation of Ca2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin. J Clin Invest (1998) 2.29

Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis. J Clin Microbiol (2001) 2.23

Alexander disease: ventricular garlands and abnormalities of the medulla and spinal cord. Neurology (2006) 2.19

Cutaneous signs. Skinmed (2003) 2.04

Anaphylaxis secondary to levobupivacaine. Anaesthesia (2011) 2.02

Mutant torsinA, responsible for early-onset torsion dystonia, forms membrane inclusions in cultured neural cells. Hum Mol Genet (2000) 1.90

Transport of Ca2+ from sarcoplasmic reticulum to mitochondria in rat ventricular myocytes. J Bioenerg Biomembr (2000) 1.87

Reversible immunocontraception in male monkeys immunized with eppin. Science (2004) 1.84

NHE-RF, a regulatory cofactor for Na(+)-H+ exchange, is a common interactor for merlin and ERM (MERM) proteins. J Biol Chem (1998) 1.75

The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation. Genes Dev (1997) 1.67

Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nat Genet (1994) 1.63

Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet (1994) 1.62

A region of deletion on chromosome 22q13 is common to human breast and colorectal cancers. Cancer Res (2000) 1.58

Prevalence & risk factors of pre-hypertension & hypertension in an affluent north Indian population. Indian J Med Res (2008) 1.58

Analysis of both TSC1 and TSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis. Hum Mutat (1999) 1.57

Comparative ultrastructure of Ca2+ release units in skeletal and cardiac muscle. Ann N Y Acad Sci (1998) 1.54

Quantification of parasite load in clinical samples of leishmaniasis patients: IL-10 level correlates with parasite load in visceral leishmaniasis. PLoS One (2010) 1.54

Tissue grafts in vitiligo surgery - past, present, and future. Indian J Dermatol (2009) 1.51

Investigation of gyrate atrophy using a cDNA clone for human ornithine aminotransferase. DNA (1986) 1.50

NHE-RF, a merlin-interacting protein, is primarily expressed in luminal epithelia, proliferative endometrium, and estrogen receptor-positive breast carcinomas. Am J Pathol (2001) 1.47

Association of mammalian trp4 and phospholipase C isozymes with a PDZ domain-containing protein, NHERF. J Biol Chem (2000) 1.46

catena-Poly[ammonium (cadmium-tri-μ-thio-cyanato-κS:N;κN:S)-1,4,10,13,16-hexa-oxa-cyclo-octa-decane (1/1)]. Acta Crystallogr Sect E Struct Rep Online (2012) 1.45

How useful is the Mantoux test in the diagnosis of doubtful cases of cutaneous tuberculosis? Int J Dermatol (2011) 1.42

Cutaneous leishmaniasis in Nepal: Leishmania major as a cause. Trans R Soc Trop Med Hyg (2008) 1.41

Eponyms in dermatology. Skinmed (2004) 1.41

Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions. Am J Hum Genet (2001) 1.39

The B1 subunit of the H+ATPase is a PDZ domain-binding protein. Colocalization with NHE-RF in renal B-intercalated cells. J Biol Chem (2000) 1.39

Localized lepromatous leprosy and its response to chemo-immunotherapy. Int J Dermatol (1994) 1.39

The intricacies of research work. Indian J Dent Res (2010) 1.38

Letter to the editors. Secondary or reinfection cutaneous tuberculosis. Trop Med Int Health (2007) 1.38

Picrorhiza kurroa (Kutaki) Royle ex Benth as a hepatoprotective agent--experimental & clinical studies. J Postgrad Med (1998) 1.37

Frequency and distribution of NF2 mutations in schwannomas. Genes Chromosomes Cancer (1996) 1.34

Molecular basis of cystathionine beta-synthase deficiency in pyridoxine responsive and nonresponsive homocystinuria. Hum Mol Genet (1993) 1.34

Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol (1995) 1.32

Smac mimetics increase cancer cell response to chemotherapeutics in a TNF-α-dependent manner. Cell Death Differ (2010) 1.29

Skin tuberculosis in children: learning from India. Dermatol Clin (2008) 1.28

Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis. PLoS Negl Trop Dis (2012) 1.27

Monitoring antimicrobial resistance in Neisseria gonorrhoeae in selected countries of the WHO South-East Asia Region between 2009 and 2012: a retrospective analysis. Sex Transm Infect (2013) 1.26

Cytokine profile of circulating T cells of leprosy patients reflects both indiscriminate and polarized T-helper subsets: T-helper phenotype is stable and uninfluenced by related antigens of Mycobacterium leprae. Immunology (1995) 1.24

Tethering of the vertebral artery in the congenital arcuate foramen of the atlas vertebra: a possible cause of vertebral artery dissection in children. Dev Med Child Neurol (2001) 1.23

The merlin tumor suppressor localizes preferentially in membrane ruffles. Oncogene (1996) 1.22

Superiority of denaturing high performance liquid chromatography over single-stranded conformation and conformation-sensitive gel electrophoresis for mutation detection in TSC2. Ann Hum Genet (1999) 1.21

Constancy of central conduction delays during development in man: investigation of motor and somatosensory pathways. J Physiol (1991) 1.21

Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas. Cancer Res (1994) 1.20

Evaluation of the usefulness of Treponema pallidum hemagglutination test in the diagnosis of syphilis in weak reactive Venereal Disease Research Laboratory sera. Indian J Sex Transm Dis (2012) 1.20

Structural alterations in cardiac calcium release units resulting from overexpression of junctin. J Mol Cell Cardiol (2001) 1.18

Dyschromatosis universalis hereditaria: report of a case and review of the literature. Pediatr Dermatol (2002) 1.18

Mutational analysis of patients with neurofibromatosis 2. Am J Hum Genet (1994) 1.17

How soon does cutaneous tuberculosis respond to treatment? Implications for a therapeutic test of diagnosis. Int J Dermatol (2005) 1.16

An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin). J Biol Chem (1994) 1.16

Alternative splicing of the tuberous sclerosis 2 (TSC2) gene in human and mouse tissues. Genomics (1995) 1.16

The neurofibromatosis 2 protein product merlin selectively binds F-actin but not G-actin, and stabilizes the filaments through a lateral association. Biochem J (2001) 1.15

Leiomyoma cutis: a clinicopathological series of 37 cases. Indian J Dermatol (2010) 1.15

Molecular analysis and prenatal diagnosis of human fumarase deficiency. Mol Genet Metab (1998) 1.14

Deletions in the ligand for CD40 in X-linked immunoglobulin deficiency with normal or elevated IgM (HIGMX-1). Int Immunol (1993) 1.13

Microdialysis perfusion of orexin-A in the basal forebrain increases wakefulness in freely behaving rats. Arch Ital Biol (2001) 1.12

Neuropathology and molecular genetics of neurofibromatosis 2 and related tumors. Brain Pathol (1995) 1.12

Morphologic and cytomorphometric analysis of exfoliated buccal mucosal cells in diabetes patients. J Cytol (2010) 1.11

Parasite detection in patients with post kala-azar dermal leishmaniasis in India: a comparison between molecular and immunological methods. J Clin Pathol (2003) 1.11

Effect of vitamin D supplementation during pregnancy on neonatal mineral homeostasis and anthropometry of the newborn and infant. Br J Nutr (2012) 1.10

Exon scanning of the entire TSC2 gene for germline mutations in 40 unrelated patients with tuberous sclerosis. Hum Mutat (1998) 1.09

Novel mutations detected in the TSC2 gene from both sporadic and familial TSC patients. Hum Mol Genet (1996) 1.09

MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p. Hum Mol Genet (1994) 1.09

DNA diagnosis of neurofibromatosis 2. Altered coding sequence of the merlin tumor suppressor in an extended pedigree. JAMA (1993) 1.09

Localization of the ornithine aminotransferase gene and related sequences on two human chromosomes. Hum Genet (1987) 1.08

Lymphoedema of the genitalia secondary to skin tuberculosis: report of three cases. Genitourin Med (1997) 1.07

Developmental expression of the tuberous sclerosis proteins tuberin and hamartin. Acta Neuropathol (2001) 1.06

Interdomain interaction of merlin isoforms and its influence on intermolecular binding to NHE-RF. J Biol Chem (1999) 1.06

Extracellular histamine levels in the feline preoptic/anterior hypothalamic area during natural sleep-wakefulness and prolonged wakefulness: an in vivo microdialysis study. Neuroscience (2002) 1.05

Foxp3 and IL-10 expression correlates with parasite burden in lesional tissues of post kala azar dermal leishmaniasis (PKDL) patients. PLoS Negl Trop Dis (2011) 1.05

Western blot analysis of humoral immune response to Leishmania donovani antigens in patients with post-kala-azar dermal leishmaniasis. Trans R Soc Trop Med Hyg (1999) 1.04

A simple and sensitive test for field diagnosis of post kala-azar dermal leishmaniasis. Br J Dermatol (2001) 1.04

Monocyte derived IL 10 and PGE2 are associated with the absence of Th 1 cells and in vitro T cell suppression in lepromatous leprosy. Immunol Lett (1995) 1.03

Serial MRI in a case of familial hemiplegic migraine. Neuroradiology (2003) 1.03

Role of Barr bodies obtained from oral smears in the determination of sex. Indian J Dent Res (2005) 1.03

Tinea capitis in the form of concentric rings in an HIV positive adult on antiretroviral treatment. Indian J Dermatol (2012) 1.02

A missense mutation (I278T) in the cystathionine beta-synthase gene prevalent in pyridoxine-responsive homocystinuria and associated with mild clinical phenotype. Am J Hum Genet (1995) 1.02

Universal absence of merlin, but not other ERM family members, in schwannomas. Am J Pathol (1997) 1.02

Endogenous ochronosis with a predominant acrokeratoelastoidosis-like presentation. Int J Dermatol (2008) 1.02

Homoplasmy, heteroplasmy, and mitochondrial dystonia. Neurology (2007) 1.02

Assessment of reactivity of three treponemal tests in non-treponemal non-reactive cases from sexually transmitted diseases clinic, antenatal clinic, integrated counselling and testing centre, other different outdoor patient departments/indoor patients of a tertiary care centre and peripheral health clinic attendees. Indian J Med Microbiol (2013) 1.01

Mucocutaneous nasal histoplasmosis in an immunocompetent young adult. Indian J Dermatol Venereol Leprol (2007) 1.01

REM sleep enhancement and behavioral cataplexy following orexin (hypocretin)-II receptor antisense perfusion in the pontine reticular formation. Sleep Res Online (1999) 1.00

Mapping of a target region of allelic loss to a 0.5-cM interval on chromosome 22q13 in human colorectal cancer. Gastroenterology (1999) 1.00

A close association of torsinA and alpha-synuclein in Lewy bodies: a fluorescence resonance energy transfer study. Am J Pathol (2001) 1.00

Post-kala-azar dermal leishmaniasis: a light and electron microscopic study of 18 cases. J Cutan Pathol (1993) 1.00

Validation of a simple resazurin-based promastigote assay for the routine monitoring of miltefosine susceptibility in clinical isolates of Leishmania donovani. Parasitol Res (2012) 1.00

Chromoblastomycosis in India. Int J Dermatol (1997) 1.00

Epidemiologic and clinicomycologic profile of onychomycosis from north India. Int J Dermatol (2008) 1.00

The murine NF2 homologue encodes a highly conserved merlin protein with alternative forms. Hum Mol Genet (1994) 1.00

Inhibition of NF2-negative and NF2-positive primary human meningioma cell proliferation by overexpression of merlin due to vector-mediated gene transfer. J Neurosurg (1999) 0.99

Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase gamma (POLG1). Arch Dis Child (2008) 0.99

A comparative analysis of root dentin transparency with known age. J Forensic Dent Sci (2010) 0.98

Adenosine, prolonged wakefulness, and A1-activated NF-kappaB DNA binding in the basal forebrain of the rat. Neuroscience (2001) 0.98